Krishna Veeraraghavan

Krishna Veeraraghavan is Global Co-Head of the firm’s Mergers & Acquisitions Group, recognized as a leading M&A practitioner.

Veeraraghavan has advised some of the world’s most prominent companies on domestic and cross-border transactions, including AB InBev in its $123 billion merger with SABMiller; Amazon.com in its $13.7 billion acquisition of Whole Foods, its $3.9 billion acquisition of One Medical and its proposed $1.4 billion acquisition of iRobot; Endeavor Energy Resources in its $26 billion merger with Diamondback Energy; The Estée Lauder Companies in its $2.8 billion acquisition of the Tom Ford brand; General Electric in its reorganization through spin-offs into separate publicly traded aviation, healthcare and energy companies; Qualcomm, alongside SSW Partners, in its $4.5 billion topping bid for Veoneer; PRA Health Sciences in its approximately $12 billion sale to ICON; Praxair in its $80 billion merger with Linde; Stemcentrx in its $9.8 billion sale to AbbVie; Synageva in its $8.4 billion sale to Alexion; Syneos Health in its $7.4 billion merger of equals with inVentiv Health and Teva in its $40.5 billion acquisition of Allergan Generics and $50.5 billion unsolicited proposal for Mylan, later withdrawn; among many others.